Mitochondrial Dysfunction and Nanotherapeutics

Marcos Roberto de Oliveira, PhD earned his bachelor’s degree in Biological Sciences at Federal University of Rio Grande do Sul (UFRGS) in 2005, followed by a master’s and a Ph.D. in Biochemistry from the same institution. He is currently a professor and coordinates research at UFRGS. His research focuses on the neuroprotection mediated by natural molecules and involves studies on mitochondrial physiology, redox biology, bioenergetics, and inflammation in both in vitro and in vivo experimental models.

• Part I - Mitochondrial Dysfunction 1. Mitochondrial dysfunction and affective disorders: Focus on diet, exercise, and aging 2. Mitochondrial dysfunction in inborn errors of metabolism 3. Impaired mitochondrial dynamics in disease 4. Mitochondrial dysfunction in metabolic disorders5. Mitochondrial dysfunction and autophagy in neurodegenerationin neurodegeneration 6. Mitochondrial dysfunction in sepsis 7. Drug or toxin induced mitochondrial toxicity 8. Aging, mitochondria, and autophagy 9. Skin aging and mitochondria Part II - Strategies utilized to deliver natural molecules to the mitochondria 10. Organelle targeting: focus on the mitochondria 11. Nanotechnology, mitochondria, and cancer 12. Nanomaterials aimed towards the cardiac mitochondria: of therapeutics to nanosafety 13. Increasing resveratrol bioavailability: a therapeutic challenge focusing on the mitochondria 14. Advances in nanotechnology-related strategies against melanoma15. Challenges in the delivery of polyphenols to cancer cells 16. Challenges in the nanoscale delivery systems development in the pharmaceutical and nutraceutical markets 17. Therapeutic implications of targeting antioxidants to the mitochondria 18. Nanomedicines and phytochemicals targeting Alzheimer’s Disease19. Mitochondria-targeted drugs and immune function 20. Polymeric Drug Delivery Systems for Mitigating Oxidative Stress21. Polyphenols and the Microbiota: A Challenge in Mitochondrial Therapy